Clinical Trial Update: To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing valsartan's impact on albuminuria and proteinuria in hypertensive patients with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Microalbuminuria, Proteinuria | Phase 4 | Status: COMPLETED